Designing Therapeutic Nanoplatforms from Marine-Derived Materials
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 5496
Special Issue Editors
Interests: drug delivery; nanotechnologies; polymer therapeutics; skin delivery; biomaterials for tissue engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Significant advances have been made in recent years towards the development of nanometric-based drug delivery systems to improve patient compliance, enhance drug safety, and reduce the administration frequency. Nanotechnologies are steadily gaining a major role in the fight against many diseases, with their development increasingly linked to the discovery of new bioactive molecules of natural origin. The marine ecosystem is now considered a primary source of active biomolecules and biomaterials for the preparation of nanostructured systems, with a constantly growing number of research papers reporting the synthesis of nanoparticles starting from marine resources. This Special Issue aims to be a repository for the most interesting contributions in this field.
In this Special Issue of Marine Drugs, you are invited to submit high-quality research papers and reviews focused on the latest advances related to the design of therapeutic nanoplatforms using materials from marine origin intended for innovative biomedical applications and smart materials. We expect to receive contributions from different areas of multidisciplinary research, including—but not restricted to—the design of innovative nanomaterials, development of new formulation strategies, surface functionalization and characterization, biological properties, and potential new therapeutic applications. We strongly believe that the contents in this Special Issue will make a significant collective contribution to this field of study and facilitate the development of new therapeutic approaches for patients.
Dr. Ovidio Catanzano
Prof. Dr. Joshua S. Boateng
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoplatforms
- bioactive marine natural products
- marine polymers for pharmaceutical applications
- marine polysaccharides
- nanomedicine
- nanotechnologies
- drug delivery
- drug targeting
- gene delivery
- protein delivery
- biomaterials
- tissue engineering
- nanofibers
